BRIEF published on 01/27/2025 at 22:20, 2 months 13 days ago Theralase's Interim Clinical Data to be Highlighted at 2025 AUA Annual Meeting Clinical Data Theralase Bladder Cancer Light-activated Therapy Urological Innovations
PRESS RELEASE published on 01/27/2025 at 22:15, 2 months 13 days ago Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting Theralase announces interim clinical data presentation at AUA Annual Meeting, showcasing promising results of light-activated Ruvidar™ in treating BCG-Unresponsive NMIBC CIS Theralase Bladder Cancer Interim Clinical Data Light-activated Ruvidar AUA Annual Meeting
BRIEF published on 12/09/2024 at 14:10, 4 months ago Theralase Expands Clinical Study Sites for Bladder Cancer Treatment in the U.S. Cancer Research Bladder Cancer Treatment Theralase Expansion Clinical Study Sites Ruvidar Activation
BRIEF published on 12/09/2024 at 14:10, 4 months ago Theralase élargit ses sites d'études cliniques pour le traitement du cancer de la vessie aux États-Unis Recherche Sur Le Cancer Expansion De La Théralase Traitement Du Cancer De La Vessie Sites D'études Cliniques Activation De Ruvidar
PRESS RELEASE published on 12/09/2024 at 14:05, 4 months ago Theralase(R) Launches Three New Clinical Study Sites in USA Theralase® launches new US Clinical Study Sites for bladder cancer treatment. Principal Investigators announced. Positive clinical data presented Clinical Data Theralase® Bladder Cancer US Clinical Study Sites
BRIEF published on 12/05/2024 at 13:05, 4 months 5 days ago Theralase Technologies Expands Bladder Cancer Study in Canada Canada Expansion Clinical Study Bladder Cancer Ruvidar Theralase Technologies
BRIEF published on 12/05/2024 at 13:05, 4 months 5 days ago Theralase Technologies étend son étude sur le cancer de la vessie au Canada Étude Clinique Cancer De La Vessie Ruvidar Technologies Théralase Expansion Au Canada
PRESS RELEASE published on 12/05/2024 at 13:00, 4 months 5 days ago Theralase(R) Launches New Clinical Study Site in Canada St. Joseph's Healthcare Hamilton joins Theralase®'s clinical investigation for bladder cancer treatment. Theralase® develops light-activated Ruvidar™ drug for BCG-Unresponsive NMIBC CIS patients Theralase® Bladder Cancer BCG-Unresponsive NMIBC CIS RuvidarTM Clinical Study Site
BRIEF published on 11/27/2024 at 23:10, 4 months 12 days ago Theralase publie son aperçu financier du troisième trimestre 2024 Placements Privés Dépenses De Recherche Et Développement Aperçu Financier De Theralase Chiffre D'affaires Et Marges Résultats De L'étude II
BRIEF published on 11/27/2024 at 23:10, 4 months 12 days ago Theralase Releases 3Q2024 Financial Overview Private Placements R&D Expenses Theralase Financial Overview Revenue And Margins Study II Results
Published on 04/10/2025 at 13:00, 16 minutes ago Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Published on 04/10/2025 at 13:00, 16 minutes ago ROK Resources Appoints New CEO & Board Member, & Files 2024 Financial Results & Management Discussion & Analysis
Published on 04/10/2025 at 13:00, 16 minutes ago Nextech3D.ai Signs Letter of Intent to Sell Share Control Block of Toggle3D.ai
Published on 04/10/2025 at 11:00, 2 hours 16 minutes ago Linear Minerals Drills 1.09 Percent Lithium Oxide Over 5 Meters at Augustus
Published on 04/10/2025 at 09:30, 3 hours 46 minutes ago Chow Tai Fook Jewellery Group Celebrates First Anniversary of Brand Transformation
Published on 04/10/2025 at 13:00, 16 minutes ago Aquis Stock Exchange - Application for Admission to Trading
Published on 04/10/2025 at 12:29, 47 minutes ago EQS-Adhoc: Wolford AG: Mandate of Ralf Polito as Member of the Management Board extended
Published on 04/10/2025 at 12:10, 1 hour 5 minutes ago Annual Shareholder Meeting of Comet Holding AG approves all agenda items
Published on 04/09/2025 at 18:59, 18 hours 16 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:59, 18 hours 16 minutes ago Descriptif du programme de rachat d'actions 2025-2026
Published on 04/09/2025 at 18:57, 18 hours 18 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 18:57, 18 hours 18 minutes ago Compte-rendu de l'Assemblée Générale Mixte du 9 avril 2025
Published on 04/09/2025 at 17:45, 19 hours 31 minutes ago COGELEC : Résultats annuels 2024 et Chiffre d’affaires du 1 er trimestre 2025.
